The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to continue a Leadership Group (LG) for a Clinical Research Network on Antibacterial Resistance (AR), which was initiated to develop, implement, and manage a clinical research program to address key clinical research
credit: From Wikipedia
questions in AR.
The LG is a cohesive program dependent on the highly integrated and complimentary activities of the four centers that comprise the network:
Scientific Leadership Center (SLC), Clinical Operations Center (COC), Laboratory Center (LC) and Statistics and Data Management Center (SDMC).